Featured Clinical Trials
Learn what’s coming down the research pipeline, and find breast cancer clinical trials you may be eligible to participate in.
Researchers seek women newly diagnosed with stage I-III breast cancer planning to undergo axillary lymph node dissection for a study on preventing and treating lymphedema.
If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery.
Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage, HER2 positive breast cancer after surgery and chemotherapy.
SWOG-S0500 is a clinical trial studying whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not.